4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-030089
CIK 0001356857operating
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 2:03 PM ET
Size
5.4 KB
Accession
0001209191-13-030089
Insider Transaction Report
Form 4
Onaitis Matthew
General Counsel
Transactions
- Award
Stock Option (right to buy)
2013-05-31+100,000→ 100,000 totalExercise: $7.67Exp: 2023-05-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on May 31, 2014, and the remainder shall vest in 36 successive equal monthly installments thereafter until fully vested on May 31, 2017.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 2:03 PM ET
- Size
- 5.4 KB